The following is a summary of “Efficacy and Safety of Tildrakizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis ...

They can also improve the look of the affected skin. Many of the standard psoriasis treatments work for plaque psoriasis, too, as this is the most common type of psoriasis. Depending on your case ...

The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

The use of risankizumab after poor response to 2 interleukin-17 inhibitors, secukinumab, and ixekizumab, was safe and effective in plaque psoriasis.

Discover a recent randomised clinical trial that evaluated the efficacy of a new monoclonal antibody to treat plaque ...

China: A new randomized clinical trial has demonstrated that QX004N, a humanized anti-IL-23 monoclonal antibody, offers ...

The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

Discover tapinarof cream 1%, a novel nonsteroidal aryl hydrocarbon receptor agonist, that has emerged as a promising solution ...

The European Medicines Agency’s (EMA) Committee for Medicinal Use Products (CHMP) recently recommended approval of six new biosimilars.

The US Food and Drug Administration (FDA) has approved Vtama (tapinarof) cream 1%, an aryl hydrocarbon receptor agonist, for ...